Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ferraro

Showing results (341-350 of 355) with videos related to

Pageof 36
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremitiesP Picci, T Böhling, G Bacci, et al.
Revue Neurologique|September 24, 2021
Endovascular treatment for acute ischemic stroke at a primary stroke center: First results of the Perpignan centerD Sablot, G Farouil, F Leibinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 30, 2018
Clinical impact of <sup>68</sup>Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introductionJulian Müller, Daniela A Ferraro, Urs J Muehlematter, et al.
Pediatric Pulmonology|January 1, 2023
Primary ciliary dyskinesia: A multicenter survey on clinical practice and patient management in ItalyNicola Ullmann, Francesca Santamaria, Annalisa Allegorico, et al.
Revue Neurologique|January 30, 2017
Results of a 1-year quality-improvement process to reduce door-to-needle time in acute ischemic stroke with MRI screeningD Sablot, N Gaillard, C Colas, et al.
American Journal of Preventive Cardiology|July 30, 2021
Ten things to know about ten cardiovascular disease risk factorsHarold E Bays, Pam R Taub, Elizabeth Epstein, et al.
Bioorganic & Medicinal Chemistry Letters|May 5, 2005
Biaryl isoxazolinone antibacterial agentsClaude A Quesnelle, Patrice Gill, Stephan Roy, et al.
Revue Neurologique|November 6, 2022
Is off-label thrombolysis safe and effective in a real-life primary stroke center? A retrospective analysis of data from a 5-year prospective databaseD Sablot, F Leibinger, A Dutray, et al.
Science Signaling|January 22, 2015
Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancerNir Ben-Chetrit, David Chetrit, Roslin Russell, et al.
Leukemia|June 5, 2014
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donorsJ Peccatori, A Forcina, D Clerici, et al.
Pageof 36

Showing results (341-350 of 355) with videos related to

Sort By:
Pageof 36
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremitiesP Picci, T Böhling, G Bacci, et al.
Revue Neurologique|September 24, 2021
Endovascular treatment for acute ischemic stroke at a primary stroke center: First results of the Perpignan centerD Sablot, G Farouil, F Leibinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 30, 2018
Clinical impact of <sup>68</sup>Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introductionJulian Müller, Daniela A Ferraro, Urs J Muehlematter, et al.
Pediatric Pulmonology|January 1, 2023
Primary ciliary dyskinesia: A multicenter survey on clinical practice and patient management in ItalyNicola Ullmann, Francesca Santamaria, Annalisa Allegorico, et al.
Revue Neurologique|January 30, 2017
Results of a 1-year quality-improvement process to reduce door-to-needle time in acute ischemic stroke with MRI screeningD Sablot, N Gaillard, C Colas, et al.
American Journal of Preventive Cardiology|July 30, 2021
Ten things to know about ten cardiovascular disease risk factorsHarold E Bays, Pam R Taub, Elizabeth Epstein, et al.
Bioorganic & Medicinal Chemistry Letters|May 5, 2005
Biaryl isoxazolinone antibacterial agentsClaude A Quesnelle, Patrice Gill, Stephan Roy, et al.
Revue Neurologique|November 6, 2022
Is off-label thrombolysis safe and effective in a real-life primary stroke center? A retrospective analysis of data from a 5-year prospective databaseD Sablot, F Leibinger, A Dutray, et al.
Science Signaling|January 22, 2015
Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancerNir Ben-Chetrit, David Chetrit, Roslin Russell, et al.
Leukemia|June 5, 2014
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donorsJ Peccatori, A Forcina, D Clerici, et al.
Pageof 36